{"id":"NCT02256436","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)","officialTitle":"A Phase III Randomized Clinical Trial of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel or Vinflunine in Subjects With Recurrent or Progressive Metastatic Urothelial Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10-22","primaryCompletion":"2016-09-07","completion":"2020-10-01","firstPosted":"2014-10-03","resultsPosted":"2017-08-31","lastUpdate":"2021-09-20"},"enrollment":542,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Urothelial Cancer"],"interventions":[{"type":"BIOLOGICAL","name":"pembrolizumab","otherNames":["MK-3475","KEYTRUDAÂ®"]},{"type":"DRUG","name":"paclitaxel","otherNames":[]},{"type":"DRUG","name":"vinflunine","otherNames":[]},{"type":"DRUG","name":"docetaxel","otherNames":[]}],"arms":[{"label":"Control","type":"ACTIVE_COMPARATOR"},{"label":"Pembrolizumab","type":"EXPERIMENTAL"}],"summary":"Participants with metastatic or locally advanced/unresectable urothelial cancer that has recurred or progressed following platinum-based chemotherapy will be randomly assigned to receive Investigator's choice of paclitaxel, docetaxel, or vinflunine (Control), or pembrolizumab. The primary study hypotheses are that pembrolizumab will prolong Overall Survival (OS) and Progression-free Survival (PFS) compared to paclitaxel, docetaxel, or vinflunine.","primaryOutcome":{"measure":"Progression-Free Survival (PFS) Per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) - All Participants","timeFrame":"Through primary analysis database cut-off date of 07-Sep-2016 (Up to approximately 20 months)","effectByArm":[{"arm":"Control","deltaMin":3.3,"sd":null},{"arm":"Pembrolizumab","deltaMin":2.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.41648"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":19},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["40037029","36494006","35247908","35101941","31395089","31050707","29590008","29562804","28212060","26454620"],"seeAlso":["http://merckoncologyclinicaltrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":104,"n":255},"commonTop":["Fatigue","Constipation","Anaemia","Nausea","Decreased appetite"]}}